News

A significant increase in walking pneumonia cases among children, largely attributed to Mycoplasma pneumoniae infections, is drawing attention from U.S. healthcare professionals.

A new study examining the effects of antimicrobial exposure on Parkinson’s disease (PD) risk has revealed insights that could influence prescribing decisions, especially concerning antibiotics and antifungal medications.

A recent study sheds light on how estrogen signaling affects immune response in breast cancer, potentially opening pathways for combined anti-estrogen and immunotherapy approaches.

Nearly half of patients with metastatic melanoma treated with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab have survived cancer-free, underscoring the impact of immunotherapy in advanced melanoma.

Duloxetine, a widely used and popular antidepressant, has been recalled by U.S. Food and Drug Administration (FDA) due to the detection of N-nitroso-duloxetine, a chemical suspected of being carcinogenic.

Hippocampal functional connectivity may be an early indicator of chronic pain development in patients following whiplash and mild traumatic brain injuries (mTBIs) according to the results of a new study.

Tusi, a new drug blend also known as “pink cocaine,” is gaining traction across Latin America, Europe, and more recently, in the United States.

The CDC has issued a health alert linking a multistate Escherichia coli (E. coli) outbreak to McDonald’s Quarter Pounders; the outbreak has spanned six states, with one death and numerous hospitalizations reported.